📰 Newspapers

White House pulls Overton's FDA nomination

White House pulls Overton's FDA nomination

Sen. Roger Marshall, R-Kansas, is being weighed as a potential replacement.

Capitol Hill is grappling with the prospect of the Food and Drug Administration operating without a Senate-confirmed leader indefinitely, after the White House pulled the nomination of Heidi Overton to lead the agency Tuesday night.

It’d been unclear whether the embattled White House official could get the necessary votes to be confirmed by the Senate’s health committee from lawmakers skeptical of her positions on vaccines, the abortion pill, and flavored vapes.

But Chair Bill Cassidy, R-La., asserted after the nomination was dropped that he believed the White House “abandoned a viable confirmation path.”

“Pro-life Senators sought final assurances from the Administration regarding the Administration’s commitment to life issues,” Cassidy said. “The Administration withdrew Dr. Overton rather than make such commitments.”

Sen. Roger Marshall, R-Kansas, is being weighed as a potential replacement, but there are questions swirling about whether anyone could be confirmed on a compressed timeline before Democrats take power.

Chris Meekins, a Raymond James healthcare analyst who worked at HHS during Trump’s first term, predicted the FDA will not have a permanent leader anytime soon, a development that “inevitably creates uncertainty.” “Had the White House heeded warnings by many before and after her nomination, they could have avoided this unfortunate outcome,” Meekins said.

— David Lim

In brief

Capitol Hill is grappling with the prospect of the Food and Drug Administration operating without a Senate-confirmed leader indefinitely, after the White House pulled the nomination of Heidi Overton to lead the agency Tuesday night. But Chair Bill Cassidy, R-La., asserted after the nomination was dropped that he believed the White House “abandoned a viable confirmation path.

This is the opening of the story, shared with credit to Semafor. The rest of the report — with every detail — continues on the publisher’s website.

Continue reading at Semafor ↗

Cookie settings

Choose which cookies we may use. You can change this at any time from Cookie settings in the footer. Details of each cookie are in the Cookie Policy.

Strictly necessary

Needed for sign-in, security, payments and remembering these choices. Always on.

Preferences

Remember settings such as dark mode.

Analytics & performance

Help us count visits, understand which pages, devices and countries our readers use, and measure how well the site performs – anonymous and aggregated.

Advertising & marketing

Lets advertising partners show and personalise adverts, measure impressions, clicks and visits, prevent ad fraud and pay us – this is how the free site is funded.

🔔 News notifications

Get headlines from NewsHub on this device — even when the site is closed.

You can switch this off at any time. Works on Android, Windows, Mac and Linux browsers; on iPhone/iPad add the site to your Home Screen first.